|Authors||Abbott DE, Baker MS, Talamonti MS|
|Journal||J Surg Oncol Volume: 101 Issue: 4 Pages: 315-20|
|Publish Date||2010 Mar 15|
The optimal therapy for pancreatic cancer continues to evolve. Neoadjuvant chemoradiation is a key component of current treatment regimens, and evaluation of previous treatment options will help guide future trials. Here the authors present a review of the current literature with discussion of future directions.